Timothy J. Poterucha, Linyuan Jing, Ramon Pimentel Ricart, Michael Adjei-Mosi, Joshua Finer, Dustin Hartzel, Christopher Kelsey, Aaron Long, Daniel Rocha, Jeffrey A. Ruhl, David vanMaanen, Marc A. Probst, Brock Daniels, Shalmali D. Joshi, Olivier Tastet, Denis Corbin, Robert Avram, Joshua P. Barrios, Geoffrey H. Tison, I-Min Chiu, David Ouyang, Alexander Volodarskiy, Michelle Castillo, Francisco A. Roedan Oliver, Paloma P. Malta, Siqin Ye, Gregg F. Rosner, Jose M. Dizon, Shah R. Ali, Qi Liu, Corey K. Bradley, Prashant Vaishnava, Carol A. Waksmonski, Ersilia M. DeFilippis, Vratika Agarwal, Mark Lebehn, Polydoros N. Kampaktsis, Sofia Shames, Ashley N. Beecy, Deepa Kumaraiah, Shunichi Homma, Allan Schwartz, Rebecca T. Hahn, Martin Leon, Andrew J. Einstein, Mathew S. Maurer, Heidi S. Hartman, John Weston Hughes, Christopher M. Haggerty, Pierre Elias
{"title":"利用人工智能从心电图中检测结构性心脏病","authors":"Timothy J. Poterucha, Linyuan Jing, Ramon Pimentel Ricart, Michael Adjei-Mosi, Joshua Finer, Dustin Hartzel, Christopher Kelsey, Aaron Long, Daniel Rocha, Jeffrey A. Ruhl, David vanMaanen, Marc A. Probst, Brock Daniels, Shalmali D. Joshi, Olivier Tastet, Denis Corbin, Robert Avram, Joshua P. Barrios, Geoffrey H. Tison, I-Min Chiu, David Ouyang, Alexander Volodarskiy, Michelle Castillo, Francisco A. Roedan Oliver, Paloma P. Malta, Siqin Ye, Gregg F. Rosner, Jose M. Dizon, Shah R. Ali, Qi Liu, Corey K. Bradley, Prashant Vaishnava, Carol A. Waksmonski, Ersilia M. DeFilippis, Vratika Agarwal, Mark Lebehn, Polydoros N. Kampaktsis, Sofia Shames, Ashley N. Beecy, Deepa Kumaraiah, Shunichi Homma, Allan Schwartz, Rebecca T. Hahn, Martin Leon, Andrew J. Einstein, Mathew S. Maurer, Heidi S. Hartman, John Weston Hughes, Christopher M. Haggerty, Pierre Elias","doi":"10.1038/s41586-025-09227-0","DOIUrl":null,"url":null,"abstract":"<p>Early detection of structural heart disease is critical to improving outcomes, but widespread screening remains limited by the cost and accessibility of imaging tools such as echocardiography<sup>1,2</sup>. Recent advances in machine learning applied to heart rhythm recordings have shown promise in identifying disease<sup>3,4</sup>, although previous work has been limited by development in narrow populations or targeting only select heart conditions<sup>5</sup>. Here we introduce a deep learning model, EchoNext, trained on more than 1 million heart rhythm and imaging records across a large and diverse health system to detect many forms of structural heart disease. The model demonstrated high diagnostic accuracy in internal and external validation, outperforming cardiologists in a controlled evaluation and showing consistent performance across different care settings and racial and/or ethnic groups. The models were prospectively evaluated in a clinical trial of patients without previous cardiac imaging, successfully identifying previously undiagnosed heart disease. These findings support the potential of artificial intelligence to expand access to heart disease screening at scale. To enable further development and transparency, we have publicly released model weights and a large, annotated dataset linking heart rhythm data to imaging-based diagnoses.</p>","PeriodicalId":18787,"journal":{"name":"Nature","volume":"29 1","pages":""},"PeriodicalIF":48.5000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detecting structural heart disease from electrocardiograms using AI\",\"authors\":\"Timothy J. Poterucha, Linyuan Jing, Ramon Pimentel Ricart, Michael Adjei-Mosi, Joshua Finer, Dustin Hartzel, Christopher Kelsey, Aaron Long, Daniel Rocha, Jeffrey A. Ruhl, David vanMaanen, Marc A. Probst, Brock Daniels, Shalmali D. Joshi, Olivier Tastet, Denis Corbin, Robert Avram, Joshua P. Barrios, Geoffrey H. Tison, I-Min Chiu, David Ouyang, Alexander Volodarskiy, Michelle Castillo, Francisco A. Roedan Oliver, Paloma P. Malta, Siqin Ye, Gregg F. Rosner, Jose M. Dizon, Shah R. Ali, Qi Liu, Corey K. Bradley, Prashant Vaishnava, Carol A. Waksmonski, Ersilia M. DeFilippis, Vratika Agarwal, Mark Lebehn, Polydoros N. Kampaktsis, Sofia Shames, Ashley N. Beecy, Deepa Kumaraiah, Shunichi Homma, Allan Schwartz, Rebecca T. Hahn, Martin Leon, Andrew J. Einstein, Mathew S. Maurer, Heidi S. Hartman, John Weston Hughes, Christopher M. Haggerty, Pierre Elias\",\"doi\":\"10.1038/s41586-025-09227-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Early detection of structural heart disease is critical to improving outcomes, but widespread screening remains limited by the cost and accessibility of imaging tools such as echocardiography<sup>1,2</sup>. Recent advances in machine learning applied to heart rhythm recordings have shown promise in identifying disease<sup>3,4</sup>, although previous work has been limited by development in narrow populations or targeting only select heart conditions<sup>5</sup>. Here we introduce a deep learning model, EchoNext, trained on more than 1 million heart rhythm and imaging records across a large and diverse health system to detect many forms of structural heart disease. The model demonstrated high diagnostic accuracy in internal and external validation, outperforming cardiologists in a controlled evaluation and showing consistent performance across different care settings and racial and/or ethnic groups. The models were prospectively evaluated in a clinical trial of patients without previous cardiac imaging, successfully identifying previously undiagnosed heart disease. These findings support the potential of artificial intelligence to expand access to heart disease screening at scale. To enable further development and transparency, we have publicly released model weights and a large, annotated dataset linking heart rhythm data to imaging-based diagnoses.</p>\",\"PeriodicalId\":18787,\"journal\":{\"name\":\"Nature\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":48.5000,\"publicationDate\":\"2025-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1038/s41586-025-09227-0\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41586-025-09227-0","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
Detecting structural heart disease from electrocardiograms using AI
Early detection of structural heart disease is critical to improving outcomes, but widespread screening remains limited by the cost and accessibility of imaging tools such as echocardiography1,2. Recent advances in machine learning applied to heart rhythm recordings have shown promise in identifying disease3,4, although previous work has been limited by development in narrow populations or targeting only select heart conditions5. Here we introduce a deep learning model, EchoNext, trained on more than 1 million heart rhythm and imaging records across a large and diverse health system to detect many forms of structural heart disease. The model demonstrated high diagnostic accuracy in internal and external validation, outperforming cardiologists in a controlled evaluation and showing consistent performance across different care settings and racial and/or ethnic groups. The models were prospectively evaluated in a clinical trial of patients without previous cardiac imaging, successfully identifying previously undiagnosed heart disease. These findings support the potential of artificial intelligence to expand access to heart disease screening at scale. To enable further development and transparency, we have publicly released model weights and a large, annotated dataset linking heart rhythm data to imaging-based diagnoses.
期刊介绍:
Nature is a prestigious international journal that publishes peer-reviewed research in various scientific and technological fields. The selection of articles is based on criteria such as originality, importance, interdisciplinary relevance, timeliness, accessibility, elegance, and surprising conclusions. In addition to showcasing significant scientific advances, Nature delivers rapid, authoritative, insightful news, and interpretation of current and upcoming trends impacting science, scientists, and the broader public. The journal serves a dual purpose: firstly, to promptly share noteworthy scientific advances and foster discussions among scientists, and secondly, to ensure the swift dissemination of scientific results globally, emphasizing their significance for knowledge, culture, and daily life.